GSA Capital Partners LLP purchased a new stake in shares of Ventas, Inc. (NYSE:VTR – Free Report) in the second quarter, HoldingsChannel.com reports. The institutional investor purchased 9,674 shares of the real estate investment trust’s stock, valued at approximately $859,000.
Several other hedge funds have also bought and sold shares of the business. Capital World Investors purchased a new stake in Ventas in the fourth quarter worth about $594,116,000. Norges Bank bought a new stake in shares of Ventas in the 4th quarter worth approximately $474,571,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Ventas by 32,509.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,648,776 shares of the real estate investment trust’s stock worth $359,722,000 after purchasing an additional 4,634,520 shares in the last quarter. Cohen & Steers Inc. grew its stake in shares of Ventas by 228.1% in the 4th quarter. Cohen & Steers Inc. now owns 4,606,355 shares of the real estate investment trust’s stock worth $356,440,000 after buying an additional 3,202,323 shares during the last quarter. Finally, Daiwa Securities Group Inc. grew its stake in shares of Ventas by 188.7% in the 4th quarter. Daiwa Securities Group Inc. now owns 4,705,591 shares of the real estate investment trust’s stock worth $364,119,000 after buying an additional 3,075,450 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.
Ventas Trading Up 0.1%
Ventas stock opened at $91.24 on Wednesday. Ventas, Inc. has a one year low of $66.38 and a one year high of $101.60. The business’s fifty day moving average is $90.86 and its 200 day moving average is $86.83. The stock has a market capitalization of $46.80 billion, a PE ratio of 168.96, a price-to-earnings-growth ratio of 2.11 and a beta of 0.69. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44.
Insider Activity at Ventas
In related news, Director Michael J. Embler acquired 2,500 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the acquisition, the director directly owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.53% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
A number of research analysts recently weighed in on VTR shares. KeyCorp raised their price objective on Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Barclays initiated coverage on Ventas in a report on Tuesday, July 7th. They issued an “equal weight” rating and a $99.00 target price on the stock. Evercore reissued an “outperform” rating and issued a $95.00 target price on shares of Ventas in a research note on Wednesday, April 29th. Jefferies Financial Group raised their price target on Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, May 12th. Finally, Raymond James Financial initiated coverage on Ventas in a research report on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 price target for the company. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Ventas presently has an average rating of “Moderate Buy” and an average target price of $98.00.
View Our Latest Stock Report on VTR
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
See Also
- Five stocks we like better than Ventas
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
